Retinal gene therapy using adeno-associated viruses (AAVs) is constrained by the mode of viral vector delivery. Intravitreal AAV injections are impeded by the internal limiting membrane barrier. while subretinal injections require invasive surgery and produce a limited region of therapeutic effect. In this study. https://macorners.shop/product-category/mug/